Events Search and Views Navigation

Event Views Navigation

Filters

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

Current

    • In-Person and Virtual R&D Day to Discuss RESTEM’s Next-Generation Immunomodulatory Treatment for Autoimmune Diseases

    Join RESTEM for an in-person and virtual R&D Day in New York to discuss the unmet needs and current treatment…
    TIME: 10:00 AM EDT
    LOCATION: Midtown NYC
    View Details

    PMV Pharmaceuticals Investor Webinar to Review Phase 2 PYNNACLE Interim Data Evaluating Rezatapopt in Patients with Advanced Solid Tumors

    Join PMV Pharmaceuticals for an investor webinar to review the interim PYNNACLE Phase 2 data and provide a regulatory update.…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    IDEAYA Biosciences 10-Year Anniversary R&D Day

    IDEAYA Biosciences (Nasdaq: IDYA) will mark its 10th anniversary with an in-person and virtual Investor R&D Day. The Company will…
    TIME: 8:00 AM EDT
    LOCATION: Midtown, New York and Live Webcast
    View Details

    Skye Bioscience Expert Panel to Offer Perspective Ahead of Phase 2a Weight Loss Data for Nimacimab, a Peripheral CB1 Inhibitor

    Join Skye Bioscience for a virtual key opinion leader (KOL) event to discuss expectations and details of upcoming topline results…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    • Virtual KOL Event to Discuss Insight Molecular Diagnostics’ In-House dd-cfDNA Testing for Kidney Transplant Patients

    Join Insight Molecular Diagnostics (iMDx) for a virtual key opinion leader (KOL) event featuring Anthony Langone, MD (Associate Professor of…
    TIME: 4:00 PM EDT
    LOCATION: Virtual
    View Details

    • Hyperion DeFi Corporate Update Event: Hyperion DeFi’s Strategic Evolution from Eyenovia and the Future of On-Chain Finance

    Join Hyperion DeFi, Inc., formerly Eyenovia, Inc., for a special corporate update event featuring CIO Hyunsu Jung and CEO Michael…
    TIME: 2:00 PM EDT
    LOCATION: Virtual
    View Details

    Oncolytics Key Opinion Leader Discussion Focusing on Pancreatic and Gastrointestinal Cancers

    Join Oncolytics for a key opinion leader (KOL) webinar to discuss pelareorep in metastatic pancreatic ductal adenocarcinoma (mPDAC) and other…
    TIME: 1:00 PM EDT
    LOCATION: Virtual
    View Details

    Bridging the Treatment Gap: Addressing Borderline Personality Disorder with Novel Therapeutics by Oryzon’s Clinical Advisory Board

    Join Oryzon Genomics for a virtual Key Opinion Leader (KOL) event exploring the significant unmet medical need and the evolving…
    TIME: 12:00 PM EDT
    LOCATION: Virtual
    View Details

    Lipocine Virtual R&D Investor Event to Discuss LPCN 1154 (BRLIZIOTM) as a Treatment for Postpartum Depression (PPD)

    Join Lipocine for a virtual R&D investor event featuring key opinion leader (KOL) Dr. Kristina M. Deligiannidis, MD (Zucker Hillside Hospital,…
    TIME: 11:00 AM EDT
    LOCATION: Virtual
    View Details

    I-Mab Biopharma KOL Webinar to Recap New Clinical Data on Givastomig (Claudin 18.2 x 4-1BB) Being Presented at ESMO GI 2025

    Join I-Mab for a KOL webinar featuring Samuel J. Klempner, MD (Associate Professor of Medicine at Massachusetts General Hospital), who…
    TIME: 2:00 PM EDT
    LOCATION: Virtual
    View Details

    • Everest Medicines: A Conversation on the Latest Results from the Ongoing Phase 1b/2a Clinical Trial of EVER001, a Next-Generation Covalent Reversible BTK Inhibitor for the Treatment of Primary Membranous Nephropathy (pMN)

    *Chinese Translation Webcast If you are having trouble seeing the player, please click here.   Join Everest Medicines for a…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    Everest Medicines: A Conversation on the Latest Results from the Ongoing Phase 1b/2a Clinical Trial of EVER001, a Next-Generation Covalent Reversible BTK Inhibitor for the Treatment of Primary Membranous Nephropathy (pMN)

    Join Everest Medicines for a virtual nephrology-focused key opinion leader (KOL) event. The event will feature: Richard Lafayette, MD – Professor…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    Crinetics Pharmaceuticals: In-Person R&D Day 2025 on CRN09682, TSH and SST3

    This page is for in-person registration only. To access the webcast, please click here.  Please join the Crinetics management team…
    TIME: 9:00 AM EDT
    LOCATION: CURE, 345 Park Ave S.
    New York, NY 10010
    View Details

    Elicio Therapeutics Virtual KOL Event to Discuss AMP-Powered ELI-002 for the Treatment of mKRAS-driven Pancreatic Cancer

    Please join the Elicio Therapeutics management team for a virtual key opinion leader (KOL) event to discuss the significant unmet…
    TIME: 2:00 PM EDT
    LOCATION: Virtual
    View Details

    Forte Biosciences Webcast to Discuss Positive Data in FB102 Celiac Disease Phase 1B Study

    Join Forte Biosciences for a conference call to discuss positive data from a Phase 1b trial in celiac disease for…
    TIME: 8:30 AM EDT
    LOCATION: Virtual
    View Details

    ArriVent Virtual Investor Event on Firmonertinib Path Forward for EGFR PACC Mutant NSCLC

    Join ArriVent for a virtual investor event to discuss the firmonertinib clinical program for the treatment of EGFR PACC mutant…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details